Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001486420-26-000003·DePinho Ronald A
Schedule 13G ownership disclosure
Tvardi Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 140755307
Event date: 2025-12-31
- Filing-level shares
- 426,190.00
- Percent of class
- 4.5%
- Ronald A. DePinho
Shares: 426,190.00 · Class: 4.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001486420-26-000003
- Form type
- SCHEDULE 13G/A
- Filer
- DePinho Ronald A
- CIK
- CIK 1486420
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership